Page last updated: 2024-11-08

biguanides and Liver Neoplasms

biguanides has been researched along with Liver Neoplasms in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xu, Y1
Liu, Y1
He, T1
Zhang, Y1
Wang, M1
Yuan, H1
Yang, M1
Chiu, CC1
Huang, CC1
Chen, YC1
Chen, TJ1
Liang, Y1
Lin, SJ1
Chen, JW1
Leu, HB1
Chan, WL1

Other Studies

2 other studies available for biguanides and Liver Neoplasms

ArticleYear
Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy.
    Colloids and surfaces. B, Biointerfaces, 2021, Volume: 207

    Topics: Biguanides; Carcinoma, Hepatocellular; Humans; Indoles; Liver Neoplasms; Nanoparticles; Serum Albumi

2021
Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:9

    Topics: alpha-Glucosidases; Biguanides; Cohort Studies; Diabetes Mellitus; Digestive System Neoplasms; Human

2013
chemdatabank.com